A new study led by scientists from the Hebrew University of Jerusalem and INSERM identified genes essential for turning embryonic stem cells into brain cells, including a gene linked to a previously ...

Which genes are required for turning embryonic stem cells into brain cells, and what happens when this process goes wrong? In a new study published today in Nature Neuroscience, researchers led by ...

I hate to break this to you, but every child is a genetic experiment – and nature doesn’t care if things go wrong. Our genomes are awful messes created by conflicting evolutionary forces, and every ...

CRISPR has incurred nearly $500 million in losses over the past four quarters. It's burning through cash as the result of its its gene-editing therapy's slow rollout. But its development partner, ...

The Champions League is wrapped up for the calendar year, yet the league phase table is still to be finalized. Only six of the league phase’s eight matchdays have been played so far, with the ...

There will be plenty of teams competing in this season’s Champions League who are more than satisfied with simply making it to the league phase. Kairat Almaty, for instance, can take great pleasure in ...

Crops around the world are under pressure from high temperatures, unpredictable weather patterns and disease. Something must be done to protect them. Gene editing in agriculture can make crops more ...

Maybe this is the season the NBA Cup really takes hold of the basketball audience. This year's quarterfinals for the NBA's in-season tournament have set up nicely, with a mix of expected title ...

Bill Whitaker is an award-winning journalist and 60 Minutes correspondent who has covered major news stories, domestically and across the globe, for more than four decades with CBS News. America's ...

The NBA Cup group stages are complete, and for the eight remaining teams, a nice payday awaits those who make it to the finals in Las Vegas. The West quarterfinalists feature the Lakers, who will take ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were ...